Network / Interactive Map / Entity profile
Confo Therapeutics
SME
Confo Therapeutics
Description
Confo Therapeutics is a biotechnology company specializing in the stabilization and targeting of GPCRs (G protein-coupled receptors) to unlock new drug targets. With their unparalleled technology, they enable the discovery of previously inaccessible drug targets. Their multi-faceted approach, including strategic partnerships and a growing pipeline of novel drug candidates, validates their value-building strategy.
Confo Therapeutics
Address
Technologiepark-Zwijnaarde 30
9052 Ghent, Belgium
9052 Ghent, Belgium
Contact
info@confotherapeutics.com
Description
Confo Therapeutics is a biotechnology company specializing in the stabilization and targeting of GPCRs (G protein-coupled receptors) to unlock new drug targets. With their unparalleled technology, they enable the discovery of previously inaccessible drug targets. Their multi-faceted approach, including strategic partnerships and a growing pipeline of novel drug candidates, validates their value-building strategy.
Matchmaking
Connect with Confo Therapeutics
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways
Not yet on COBIOE directory?
Want to access to more data?
Want to contact this entity?